glp 1 agonists and depression Glucagon-like peptide-1 receptor risk of suicidality among patients with type 2 diabetes: active comparator, new user cohort study Reassuring' findings suggest GLP-1 receptor
Description
doi: 10.3389/fendo.2023.1085799 Received 31 October 2022 Accepted 02 January 2023 Published 01 February 2023 Volume 14 - 2023 Edited by Xiaodong Sun, Affiliated Hospital of Weifang Medical University, China Reviewed by Kefei Dou, Chinese Academy of Medical Sciences and Peking Union Medical College, China
avoid freezing
Diabetes Care (2022) 45(Suppl 1):S12543
after the first year
Pharmacological profile of lixisenatide: A new GLP-1 receptor agonist for the treatment of type 2 diabetes
[DOI] [PMC free article] [PubMed] [Google Scholar] 152.Gutniak M, Orskov C, Holst JJ, et al
